CAPTRUST Financial Advisors
PBYI icon

CAPTRUST Financial Advisors’s Puma Biotechnology PBYI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,500
Closed -$4K – 3440
2022
Q2 		$4K Hold
1,500
– – ﹤0.01% 4203
2022
Q1 		$4K Hold
1,500
– – ﹤0.01% 4263
2021
Q4 		$5K Sell
1,500
-114
-7% -$495 ﹤0.01% 4088
2021
Q3 		$11K Buy
1,614
+114
+8% +$854 ﹤0.01% 3553
2021
Q2 		$14K Hold
1,500
– – ﹤0.01% 3351
2021
Q1 		$15K Buy
+1,500
New +$16.8K ﹤0.01% 3200
2019
Q2 		– Sell
-1,306
Closed -$51K – 1987
2019
Q1 		$51K Buy
+1,306
New +$39.9K ﹤0.01% 901

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return